The global bee venom extract market size was valued at USD 0.35 billion in 2024. The global market size is estimated to reach USD 0.54 billion by 2033 from USD 0.37 billion in 2025, growing at a CAGR of 4.90% from 2025 to 2033.
Apitoxin is the alternative name for bee venom, a colourless bitter liquid. According to the American Apitherapy Association, apitherapy is the therapeutic means of using products made by bees, such as bee venom and honey. For ailments where Western drugs don't work, bee venom treatment is used when bee venom is used for treatment. A few of the functions of bee venom are arthritis remedies, anti-inflammatory drugs, pain relief, and other reports, including acne, psoriasis, and skin cancer scars. It takes almost 10,000 bee stings to produce one gram of bee venom. This makes the poison almost seven times more expensive than silver.
The global bee venom extract market has had steady growth in recent years and is likely to hold a prominent future in the coming years. The awareness of the capabilities of bee venom extracts in the medical and skincare applications has increased exponentially in various countries and resulting in the rapid adoption and increasing usage worldwide. Bee venom extract has diverse therapeutic properties that range from anti-inflammatory and analgesic to antimicrobial and anticancer effects and is being used to as an ingredient to innovate and manufacture various products in the medical and cosmetic applications. In recent years, the demand for bee venom extract has considerably increased in the U.S., the UK, Canada, Germany, Spain, South Korea, and Japan due to the growing popularity of bee venom-based products in skincare and alternative medicine. The rising demand worldwide for natural and sustainable ingredients and growing awareness of the potential health benefits of bee venom extract and increasing research into its medicinal uses will continue to drive and expand the global market during the forecast period.
For instance, bee venom has been used mainly in Europe for several decades, especially for the treatment of rheumatic diseases. Live bees, as well as venom extracts, are used for treatment in Europe. People are entering into the business of bee venom due to the fact that profitability has also increased gradually over the last few years. The promising therapeutic potential across multiple medical applications is primarily fueling the demand for bee venom extract in multiple countries. Bee venom is a mixture of peptides, enzymes, and bioactive compounds and has diverse pharmacological properties such as anti-inflammatory, analgesic, antimicrobial and anticancer effects. According to a study published in Toxins Journal, bee venom has the ability to induce apoptosis in cancer cells and inhibit tumor growth and can be used in cancer therapy. In addition to that, awareness of the ability of bee venom to treat inflammatory conditions such as rheumatoid arthritis and osteoarthritis is also increasing in several countries. As per the research published by the Evidence-Based Complementary and Alternative Medicine, bee venom acupuncture can effectively reduce pain and improve the functionality between the joints in arthritis patients. In the coming future, the demand for bee venom extract is expected to see a notable surge due to the increasing R&D activities by researchers to explore the medicinal benefits of bee venom extract.
Extracting the venom from bees is not an easy task and comes with many challenges. Previously, bees were captured when the bees returned to their hives and gave electrical shock waves, and were squeezed between the rollers to sew. However, during this process, many bees are crushed, and the venom is also contaminated. In another method, the bees are made to sting the plastic or rubber dam. The invention of bee extraction equipment that allows producers to simply extract bee venom from the hive has gained popularity in several countries and made the task of extracting the venom from bees less complex compared to earlier days. The device is inserted below the brood chamber of a bee colony. However, the main limitation when collecting bee venom lies in the support techniques, which result in the death of the bee if not handled properly.
The apitherapy has gained popularity worldwide, and the adoption of apitherapy has seen a notable increase in recent years. Apitherapy is a form of alternative medicine and holds potential health benefits. Several leading healthcare organizations have realized the potential of apitherapy and acknowledged it as traditional medicine and are supporting the research to explore the effectiveness of apitherapy. Bee venom therapy is effective in reducing chronic low back pain and can be considered a treatment plan for musculoskeletal disorders, as found in a study conducted by the Journal of Pharmacopuncture. The number of healthcare practitioners considering bee venom therapies in their treatment protocols is also increasing, according to reports from the American Apitherapy Society. Likewise, an increase in the number of healthcare providers and consumers seeking natural and holistic healthcare alternatives such as apitherapy is supporting the expansion of the global bee venom extract market.
Furthermore, factors such as the increasing usage of bee venom extract to innovate and develop anti-aging and anti-inflammatory products, the expansion of beekeeping practices globally, and the growing usage of bee venom extract in treating chronic conditions are promoting global market growth. A favorable regulatory environment for bee products, rising emphasis on natural pain relief alternatives, and increasing investments around R&D of bee venom products are further favoring the growth rate of the bee venom extract market.
Research around apitherapy has been ongoing for a long time in many countries. Still, there is inadequate awareness and understanding of the potential of apitherapy in several parts of the world. This limited availability of education and information about apitherapy in healthcare systems and among the general public are also resulting in the limited adoption of bee venom extract in many countries. For instance, in a survey by the World Beekeeping Association, only 37% of the participants reported that they are aware of apitherapy and its significance as a therapeutic practice. The potential adverse reactions and allergies associated with the usage of bee venom extract in some people, lack of standardized quality control measures and limited availability of skilled apitherapists are hampering the expansion of the global market. High costs associated with the production of bee venom extracts, the availability of synthetic alternatives and limited scientific evidence supporting efficacy are further impeding the growth of the global market.
REPORT METRIC |
DETAILS |
Market Size Available |
2024 to 2033 |
Base Year |
2024 |
Forecast Period |
2025 to 2033 |
CAGR |
4.90% |
Segments Covered |
By Application, Form, and Region. |
Various Analyses Covered |
Global, Regional and Country Level Analysis; Segment-Level Analysis; DROC; PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
Market Leaders Profiled |
Abeeco Pure, Bee Whisper, Fernz, ApiHealth NZ Ltd. |
The cosmetic and personal care segment dominated the market, holding 60.8% of the global market share in 2023. The cosmetic and personal care segment is predicted to register a healthy CAGR during the forecast period. The rising preference from consumers for natural ingredients, increasing disposable income and the growing popularity of anti-aging products are primarily propelling the expansion of the cosmetic and personal care segment in the global market. The rising trend towards clean beauty products is driving the adoption of bee venom-based cosmetics and contributing to the segmental expansion. The usage of bee venom in cosmetic and personal care products is high in South Korea, the United States, and Japan.
On the other hand, the pharmaceutical segment accounted for a substantial share of the global market in 2023 and is estimated to be the fastest-growing segment during the forecast period. The growing R&D activities to explore the therapeutic potential of bee venom compounds, increasing investments by pharmaceutical companies to develop bee venom-based drugs and regulatory approvals for bee venom-based pharmaceutical products for various indications are boosting the growth of the pharmaceutical segment primarily.
The liquid segment led the market in 2023 and held 58.7% of the global market share and is predicted to grow at a healthy CAGR during the forecast period. North America and Europe are the largest consumers of liquid bee venom and account for 70% of the share in usage worldwide. The major market participants such as Abeeco, ApiHealth NZ Ltd., and Bee Whisper ApS have been putting significant efforts in expanding their production capacities and distribution networks, and their products in liquid form are their major.
The powder segment is also major segment and is projected to register a promising CAGR during the forecast period owing to factors such as increasing demand for powered bee venom products from Asia-pacific countries such as China and South Korea, rapid adoption of powdered bee venom in veterinary medicine and increasing usage of powdered bee venom in nutraceuticals and dietary supplements.
North America outranked all the other regions and held 31.9% of the worldwide market share in 2023. North America is a leader in the bee venom extract market due to strong demand for natural skincare, alternative therapies, and anti-inflammatory products. The U.S., in particular, is a significant consumer, as bee venom is used increasingly in luxury skincare and arthritis treatments. With growing interest in natural wellness and alternative therapies, the market in North America is predicted to expand steadily. Investment in research for therapeutic applications is also contributing to the region’s market strength.
Europe was the second-largest regional segment in the global market in 2023. Europe has a well-established market for bee venom extract, with demand driven by the beauty and skincare industry. Countries such as Germany, France, and the U.K. lead the market, given the popularity of bee venom in anti-aging and therapeutic products. The European Union’s regulations on natural ingredients and consumer demand for sustainable products are supporting growth in this market. Continued demand for organic and eco-friendly skincare products is expected to fuel expansion in the coming years.
Asia-Pacific is the fastest-growing region and is projected to grow at a rapid CAGR of 13.38% over the forecast period. The growth of the bee venom extract market in the Asia-Pacific region is fueled by traditional medicine practices and a rising interest in natural therapies, especially in countries like South Korea, China, and Japan. South Korea leads the region due to the popularity of K-beauty, where bee venom is widely used in anti-aging and acne treatments. The demand for natural ingredients in cosmetics and increasing disposable income are likely to boost this market. This region’s potential is underscored by strong consumer preference for health and wellness products with natural origins.
Latin America is anticipated to grow at a moderate CAGR over the forecast period. The bee venom extract market in Latin America is emerging, with Brazil and Mexico leading due to a growing demand for natural remedies and alternative therapies. The region’s expanding cosmetics industry and increasing consumer awareness of natural skincare products are contributing to market growth. Despite challenges with lower R&D funding and limited accessibility, the market is expected to grow as awareness of bee venom’s benefits for health and skincare increases.
The bee venom extract market in MEA is in its early stages, with growth driven by increasing interest in natural medicine and wellness. The United Arab Emirates and South Africa are leading markets in this region, as demand for premium skincare products rises. While infrastructure and research funding are limited, the market is expected to expand gradually as consumer awareness of bee venom’s potential therapeutic benefits grows, alongside interest in holistic health products.
Companies playing a significant role in the global bee venom extract market include Abeeco Pure, Bee Whisper, Fernz and ApiHealth NZ Ltd.
This research report on the global bee venom extract market has been segmented and sub-segmented based on application, form and region.
By Application
By Form
By Region
Frequently Asked Questions
Bee Venom Extract Market Can be Predicted Reach A Valuation Of USD 0.42 Billion by 2028
Bee Venom Extract Market Can Expand With A CAGR 4.90 % in a given Forecast Period.
Abeeco Pure
Bee Whisper, Fernz
ApiHealth NZ Ltd
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region